Skip to main content
. 2022 May 26;10:895284. doi: 10.3389/fcell.2022.895284

FIGURE 4.

FIGURE 4

Histopathological assessment of patient tumor and tumor organoid (A) Ki67 staining of the colon cancer organoids and original tumor (B) CDX2 staining of the colon cancer organoids and original tumor. Both stain intensity and presence quantified ki67 and CDX2. Intensity defines staining strength, and presence is expressed as the percentage of cells with staining. The staining intensity is evaluated within the nuclear fraction. Scale bar: 50 μm and 100 μm, ×200 and ×400 magnification.